Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection

Journal of Virology
Kevin O SaundersGary J Nabel

Abstract

Pathogen-specific neutralizing antibodies protect against many viral infections and can potentially prevent human immunodeficiency virus (HIV) transmission in humans. However, neutralizing antibodies have so far only been shown to protect nonhuman primates (NHP) against lentiviral infection when given shortly before challenge. Thus, the clinical utility and feasibility of passive antibody transfer to confer long-term protection against HIV-1 are still debated. Here, we investigate the potential of a broadly neutralizing HIV-1 antibody to provide long-term protection in a NHP model of HIV-1 infection. A human antibody was simianized to avoid immune rejection and used to sustain therapeutic levels for ∼5 months. Two months after the final antibody administration, animals were completely protected against viral challenge. These findings demonstrate the feasibility and potential of long-term passive antibody for protection against HIV-1 in humans and provide a model to test antibody therapies for other diseases in NHP. Antibodies against HIV are potential drugs that may be able to prevent HIV infection in humans. However, the long-term protective capacity of antibodies against HIV has not been assessed. Here, we repetitively admini...Continue Reading

References

Jan 12, 1989·Nature·N E Simister, K E Mostov
Jul 24, 2002·Immunogenetics·Jason M LinkHarry W Schroeder
Apr 3, 2003·Immunogenetics·Jon M BibleDeborah K Dunn-Walters
Apr 18, 2003·Current Molecular Medicine·John R Mascola
Jul 2, 2003·Nature Medicine·Melissa Pope, Ashley T Haase
Jul 5, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Ranajit PalMarvin Reitz
Feb 19, 2004·Methods in Molecular Biology·Benny K C Lo
Sep 23, 2006·Expert Review of Vaccines·Barton F Haynes, David C Montefiori
Jun 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stanley A Plotkin
Jan 19, 2010·Nature Biotechnology·Jonathan ZalevskyJohn R Desjarlais
Aug 19, 2011·Nature·Laura M WalkerPascal Poignard
Nov 4, 2011·MAbs·Timothy T Kuo, Victoria G Aveson
Feb 9, 2012·Cold Spring Harbor Perspectives in Medicine·Julie Overbaugh, Lynn Morris
Jul 13, 2012·The New England Journal of Medicine·Lut Van DammeUNKNOWN FEM-PrEP Study Group
Oct 27, 2012·Proceedings of the National Academy of Sciences of the United States of America·Brian MoldtDennis R Burton
Feb 13, 2013·The Journal of Experimental Medicine·Laura E McCoy, Robin A Weiss
Aug 24, 2013·Nature Reviews. Immunology·Peter D KwongGary J Nabel
Jul 6, 2014·Science Translational Medicine·Amarendra PeguGary J Nabel

❮ Previous
Next ❯

Citations

Apr 3, 2016·Current Opinion in Immunology·Peter Sondermann, David E Szymkowski
Oct 18, 2016·Frontiers in Immunology·Ming SunYiming Shao
Dec 23, 2016·The Journal of Experimental Medicine·Amelia EscolanoMichel C Nussenzweig
Jan 31, 2017·Immunological Reviews·Amarendra PeguNancy L Haigwood
Jan 31, 2017·Immunological Reviews·George K LewisAnthony L DeVico
Jan 31, 2018·Nature Reviews. Immunology·Laura M Walker, Dennis R Burton
Jul 21, 2015·Viruses·Elena Herrera-Carrillo, Ben Berkhout
Apr 24, 2018·Human Vaccines & Immunotherapeutics·Yunda HuangPeter B Gilbert
May 24, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Binoy RajanLars Austbø
Dec 14, 2017·Frontiers in Immunology·Casey K Hua, Margaret E Ackerman
Apr 5, 2019·Current Opinion in HIV and AIDS·Andrew T McGuire
Sep 17, 2016·Current Opinion in HIV and AIDS·Jeffrey T Safrit, Wayne C Koff
Sep 26, 2017·PLoS Pathogens·Gregory Q Del PreteTheodora Hatziioannou
Oct 13, 2019·Scientific Reports·Reda RawiGwo-Yu Chuang
Nov 18, 2018·Retrovirology·Henning Gruell, Florian Klein
Apr 1, 2020·Current HIV Research·Chringma SherpaStuart F J Le Grice
Jun 15, 2017·Drug Delivery and Translational Research·William R LykinsTejal A Desai
Jan 5, 2017·PLoS Pathogens·Nicole A Doria-RoseIvelin S Georgiev
Apr 20, 2017·Current Opinion in HIV and AIDS·Matthew R Gardner, Michael Farzan
Jul 17, 2018·The Journal of Infectious Diseases·Alberto CagigiNancy J Sullivan
Mar 25, 2019·Current HIV/AIDS Reports·Audrey L ButlerGalit Alter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.